GR
Gundluru Reddeppa
About Gundluru Reddeppa
Data last updated:
Gundluru Reddeppa is a Director at Spectrogen Pharmachem Limited (since 2024), Director at Venmax Drugs And Pharmaceuticals Limited (since 2024) and Director at Omega Ag Seeds Punjab Limited (since 2024). The companies operate in Pharma and Agriculture. The 3 current companies with reported revenue have a combined latest revenue of ₹10.65 Cr; the largest is Spectrogen Pharmachem Limited at ₹8.21 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Jan 2024 | 2020 | ₹8.21 Cr (FY 2023) | Active | |
| Director | 22 Aug 2024 | 1988 | ₹1.86 Cr (FY 2025) | Active | |
| Director | 22 Aug 2024 | 1992 | ₹57.8 Lakh (FY 2025) | Active |
Board colleagues of Gundluru Reddeppa
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gundluru Reddeppa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gundluru Reddeppa
Gundluru Reddeppa currently holds 3 directorships: Spectrogen Pharmachem Limited (Director, since 17 Jan 2024, revenue ₹8.21 Cr (FY 2023)); Venmax Drugs And Pharmaceuticals Limited (Director, since 22 Aug 2024, revenue ₹1.86 Cr (FY 2025)); Omega Ag Seeds Punjab Limited (Director, since 22 Aug 2024, revenue ₹57.8 Lakh (FY 2025)).
Gundluru Reddeppa was first appointed on 17 Jan 2024 as Director at Spectrogen Pharmachem Limited.
The 3 current companies of Gundluru Reddeppa that report revenue have a combined latest revenue of ₹10.65 Cr: Spectrogen Pharmachem Limited ₹8.21 Cr (FY 2023); Venmax Drugs And Pharmaceuticals Limited ₹1.86 Cr (FY 2025); Omega Ag Seeds Punjab Limited ₹57.8 Lakh (FY 2025).
The current boards of Gundluru Reddeppa's companies include Bhushanam Busi (Spectrogen Pharmachem Limited), Mounika Arshakota (Spectrogen Pharmachem Limited), Srinivasa Raju Marni (Spectrogen Pharmachem Limited), Vyasmurti Madhavrao Shingatgeri (Spectrogen Pharmachem Limited), Dakshita Jain (Venmax Drugs And Pharmaceuticals Limited), Dasi Reddy Rakesh (Venmax Drugs And Pharmaceuticals Limited), among others.